Nevihostényi G, Gyetvai G, Kiss B, Csizer Z, Istók M, Kósa E
Allerg Immunol (Leipz). 1979;25(4):268-74.
Authors were studying the relationship between the history data, the diagnostic difficulties, the skin tests and ventilatory functions after provocative inhalation and specific IgE positivity in connection with 40 cases of bronchial asthma. The most important feature of the treatment is the specific hyposensibilisation, which was performed by a depot house-dust preparation, manufactured by the Vaccine Producing Institute "Human", Budapest. Full success was given in 61,1% of the treated asthmatics.
作者们针对40例支气管哮喘患者,研究了病史数据、诊断困难程度、激发吸入后的皮肤试验及通气功能与特异性IgE阳性之间的关系。治疗的最重要特征是特异性减敏疗法,该疗法采用由布达佩斯“人类”疫苗生产研究所生产的长效屋尘制剂进行。61.1%接受治疗的哮喘患者取得了完全成功。